Cor Therapeutics, Inc. - Securities Class Action

Company and Case Information

IMPORTANT INFORMATION | INDEX OF FILINGS | SEARCH

Home

Index of Filings

News and Press Releases

Filings

Decisions

Settlements

Litigation Activity Indices

Top Ten List

Annual/Quarterly Updates

Clearinghouse Research

Articles & Papers

Search

Related Sites

About Us

Local Rules

Sponsors

Register

_______________
Copyright (c) 2001
Stanford Law School

Cor Therapeutics, Inc. Conclusion: According to the docket posted and the Company's Form 10-Q for the quarterly period ended June 30, 1998, plaintiff and the defendant have agreed that plaintiff will voluntarily dismiss all claims against all defendants in that action. On May 18, 1998, the Stipulation and Order by Judge Ronald M. Whyte dismissed the case.

The complaint charges Cor and certain of its officers and directors with violations of the Securities Exchange Act of 1934. Specifically, the complaint alleges that throughout the Class Period, defendants caused Cor to disseminate, through public statements and SEC filings, false and misleading statements about the results of the clinical trials for its drug Integrilin for use in patients with unstable angina and non-Q-wave myocardial infarction. The complaint further alleges that defendants engaged in this wrongful conduct for the purpose of allowing the Company to raise more than $59 million in proceeds by completing a public offering of Cor common stock at artificially inflated prices.

INDUSTRY CLASSIFICATION:
SIC Code: 2834
Sector: Healthcare
Industry: Biotechnology & Drugs

COMPANY/ISSUER NAME:	Cor Therapeutics, Inc.
COMPANY/ISSUER TICKER:	CORR
COMPANY WEBSITE:	http://www.corr.com

FIRST IDENTIFIED COMPLAINT IN THE DATABASE

Robert Leff, et al. v. Cor Therapeutics, Inc., et al.

COURT: N.D. California	DOCKET NUMBER: 98-CV-20104
JUDGE NAME: Hon. Ronald M. Whyte
DATE FILED: 01/30/1998	SOURCE: Internet
CLASS PERIOD START: 08/25/1997	CLASS PERIOD END: 01/28/1998
TYPE OF COMPLAINT: Unamended/Unconsolidated
PLAINTIFF FIRMS IN THIS OR SIMILAR CASE:
Bernstein Litowitz Berger & Grossmann LLP (Westfield, NJ) 220 St. Paul Street, Westfield, NJ, 07090 (voice) 908.928.1700, (fax) 908.301.9008, blbg@blbglaw.com Milberg Weiss Bershad Hynes & Lerach LLP (San Diego, CA) 600 West Broadway, 1800 One America Plaza, San Diego, CA, 92101 (voice) 800.449.4900, (fax) , support@milberg.com _____________________________________________ TOTAL NUMBER OF PLAINTIFF FIRMS: 2

DOCUMENTS FOR THE FIRST IDENTIFIED COMPLAINT
Class Action Complaint for Violations of the Federal Securities Laws
Type: Complaint		Date on the document: 01/30/1998
CIVIL DOCKET FOR CASE #: 98-CV-20104
Type: Docket		Date on the document: 06/05/1998
Party and Counsel List
Type: Other		Date on the document: 06/05/1998

OTHER DOCUMENTS

Case Name and/or Number:
Type:		Date on the document:

WARNING AND DISCLAIMER OF LIABILITY:
The information included on this Web site, whether provided by personnel employed by Stanford Law School or by third parties, is provided for research and teaching purposes only. Neither Stanford University, Stanford Law School, nor any of their employees, agents, contractors, or affiliates warrant the accuracy or completeness of the information or analyses displayed herein, and we caution all readers that inclusion of any information on this site does not constitute an endorsement of the truthfulness or accuracy of that information. In particular, this Web site contains complaints and other documents filed in federal and state courts, which make allegations that may or may not be accurate. No reader should, on the basis of information contained in or referenced by this Web site, assume that any of these allegations are truthful.

Go to Search page | Go to Case Index page | Back to Top

�